This company has shut down. Poseida Therapeutics is no longer operating — its last tracked round was a Post-IPO Equity in 2023.
Explore the Startup GraveyardPoseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Poseida Therapeutics has raised $25.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2023.
Poseida Therapeutics's investors include Vivo Capital, Perceptive Advisors, Novartis, Fidelity, Longitude Capital.
Poseida Therapeutics is headquartered in San Diego, United States.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Poseida Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Poseida Therapeutics — Funding & Investors." VCBacked, August 7, 2023, https://www.vcbacked.co/company/poseida-therapeutics. Accessed July 20, 2026.
VCBacked. (2023). Poseida Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/poseida-therapeutics
{{cite web |title=Poseida Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/poseida-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated